Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Merck & Co Inc
MRK
Healthcare
Merck & Co., Inc. is a research-intensive biopharmaceutical company engaged in research to deliver health solutions that advance the prevention and treatment of diseases in people and animals. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for...
the treatment of human disorders. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. It is also engaged in developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:MRK)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 03, 2024 6:45am
New Press Release - FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations
First breakthrough therapy designation for investigational sac-TMT in the U.S. Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sacituzumab tirumotecan (sac...
read article.
(28)
•••
SharpFocus619
X
Post by
SharpFocus619
on Nov 27, 2024 7:19pm
MRK at $100: Buy the Dip or Wait?
MRK holding $100 looks tempting, but I’m cautious. Guidance cuts and pipeline questions make me hesitant to jump in without a clearer technical breakout above $105. Meanwhile, I’ve got BOLT on my
...more
Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents
posted Dec 03, 2024 9:00am by
Revive Therapeutics Ltd
-
|
Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more
(19)
•••
TradeVision2001
X
Post by
TradeVision2001
on Nov 27, 2024 6:58pm
Keytruda SC: Big Win or Overhyped?
Keytruda’s SC version is a huge step forward—faster for patients and clinics. But will it hit margins for infusion centers? Oncology still dominates, but MRK’s reliance on Keytruda is risky long-term.
...more
(17)
•••
RapidInvestor5
X
Post by
RapidInvestor5
on Nov 25, 2024 4:42pm
$MRK Leads Recovery in Drug Manufacturing as $MYNZ Stays on
$MRK is in the green today after being heavily dropped following its report and two downgrades. It’s the winner in the drug manufacturing sector today. Keeping an eye on $MYNZ as it might react to
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Jul 30, 2024 10:17pm
Merck (MRK) Q2 2024 Earnings Call Transcript
JUST IN: $MRK Merck (MRK) Q2 2024 Earnings Call Transcript2024-07-30 14:15:13 ET Image source: The Motley Fool. Merck (NYSE: MRK) Q2 2024 Earnings Call Jul 30, 2024 , 9:00 a.m. ET Operator Continue
...more
(3016)
•••
Betteryear2
X
Post by
Betteryear2
on Apr 26, 2024 9:07pm
Merck beats earnings expectations (MRK)
601 Views Apr 25, 2024 CNBC's Joe Kernen reports on the company's quarterly earnings results. Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales (youtube
...more
(3016)
•••
Betteryear2
X
Post by
Betteryear2
on Apr 26, 2024 9:05pm
Merck Announces First-Quarter 2024 Financial Results (MRK)
April 25, 2024 06:30 AM Eastern Daylight Time RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the first
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Mar 04, 2024 9:30pm
Merck to Participate in the Leerink Partners Global Biopharm
BREAKING NEWS: $MRK Merck to Participate in the Leerink Partners Global Biopharma Conference 2024Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Dr
...more
(128)
•••
Goodtoreadthis1
X
Post by
Goodtoreadthis1
on Jun 27, 2022 2:25pm
Fear of recession overblown
https://mail.google.com/mail/u/0/#inbox/FMfcgzGpGdlhJzgczCNrqdzVqkFjpqbV
(2)
•••
zeropointenergy
X
Post by
zeropointenergy
on Oct 06, 2021 7:18am
ONE DRUG PILL WIPES OUT COVID 19!
India's Ivermectin Blackout - Part V: The Secret Revealed ... Sep 27, 2021 · By September 12, 2021, Livemint reported that 34 districts were declared COVID-free
...more
(28)
•••
anjz661
X
Post by
anjz661
on Oct 03, 2021 8:04am
Share Price
Surprised the share price didn't pop more than it did given the news release.
(3)
•••
Mil_Man54
X
Post by
Mil_Man54
on Dec 19, 2020 3:46pm
Bonvoyage12....Ignorant Pumper
Bonvoyage12, wendhie05, Slasher94, and now dayanpantig, miningdude39, fsdpharma, and shroomtrip59....and now more....all relentlessly pumping HUGE, GRAT, and TRIP....ignore them....report them....and
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Rig Count Soars as Utilization Surpasses Industry Averages